MedPath

Mechanisms Underlying Drug-Diet Interactions

Not Applicable
Completed
Conditions
Pharmacokinetics
Interventions
Registration Number
NCT01034124
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

Similar to the well publicized "grapefruit juice effect", ongoing studies are evaluating the interaction potential of other dietary substances on drug disposition. This study is designed to determine whether the mechanism underlying the enhancement of the anticoagulative effect of warfarin by cranberry juice is due to inhibition of warfarin metabolism by the juice. A secondary objective is to determine whether cranberry juice elicits a grapefruit juice-type interaction with midazolam.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • 18-65 years of age
  • Healthy
  • Not taking medications known to modulate CYP2C9 and CYP3A activity
  • Able to understand the consent process
Read More
Exclusion Criteria
  • Allergy to cranberry products, warfarin, vitamin K, or midazolam
  • Pregnant or breast-feeding women
  • Baseline INR >1.2
  • History of significant medical conditions that could increase risk
  • Concomitant medications known to modulate CYP2C9 and CYP3A activity
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Waterwarfarin, vitamin K, midazolam-
Cranberry juicewarfarin, vitamin K, midazolam-
Primary Outcome Measures
NameTimeMethod
AUC0-96 hr
Secondary Outcome Measures
NameTimeMethod
Cmaxvaries

Trial Locations

Locations (1)

UNC-Chapel Hill General Clinical Research Center

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath